154 related articles for article (PubMed ID: 12057736)
1. Pharmacokinetics and pharmacodynamics of single-chain recombinant human follicle-stimulating hormone containing the human chorionic gonadotropin carboxyterminal peptide in the rhesus monkey.
Klein J; Lobel L; Pollak S; Ferin M; Xiao E; Sauer M; Lustbader JW
Fertil Steril; 2002 Jun; 77(6):1248-55. PubMed ID: 12057736
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of recombinant human follicle stimulating hormone after intravenous, intramuscular, and subcutaneous administration in monkeys, and comparison with intravenous administration of urinary follicle stimulating hormone.
Porchet HC; Le Cotonnec JY; Canali S; Zanolo G
Drug Metab Dispos; 1993; 21(1):144-50. PubMed ID: 8095209
[TBL] [Abstract][Full Text] [Related]
3. The population pharmacokinetics of recombinant- and urinary-human follicle stimulating hormone in women.
Karlsson MO; Wade JR; Loumaye E; Munafo A
Br J Clin Pharmacol; 1998 Jan; 45(1):13-20. PubMed ID: 9489588
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of recombinant and urinary human FSH in the male monkey (Macaca fascicularis).
Weinbauer GF; Simoni M; Hutchison JS; Nieschlag E
J Endocrinol; 1994 Apr; 141(1):113-21. PubMed ID: 8014594
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone.
le Cotonnec JY; Loumaye E; Porchet HC; Beltrami V; Munafo A
Fertil Steril; 1998 Feb; 69(2):201-9. PubMed ID: 9496329
[TBL] [Abstract][Full Text] [Related]
6. A bolus of recombinant human follicle stimulating hormone at midcycle induces periovulatory events following multiple follicular development in macaques.
Zelinski-Wooten MB; Hutchison JS; Hess DL; Wolf DP; Stouffer RL
Hum Reprod; 1998 Mar; 13(3):554-60. PubMed ID: 9572409
[TBL] [Abstract][Full Text] [Related]
7. Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females.
Duijkers IJ; Klipping C; Boerrigter PJ; Machielsen CS; De Bie JJ; Voortman G
Hum Reprod; 2002 Aug; 17(8):1987-93. PubMed ID: 12151425
[TBL] [Abstract][Full Text] [Related]
8. First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization.
Beckers NG; Macklon NS; Devroey P; Platteau P; Boerrigter PJ; Fauser BC
Fertil Steril; 2003 Mar; 79(3):621-3. PubMed ID: 12620451
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady state pharmacokinetics.
le Contonnec JY; Porchet HC; Beltrami V; Khan A; Toon S; Rowland M
Fertil Steril; 1994 Apr; 61(4):679-86. PubMed ID: 8150110
[TBL] [Abstract][Full Text] [Related]
10. First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.
Bouloux PM; Handelsman DJ; Jockenhövel F; Nieschlag E; Rabinovici J; Frasa WL; de Bie JJ; Voortman G; Itskovitz-Eldor J;
Hum Reprod; 2001 Aug; 16(8):1592-7. PubMed ID: 11473948
[TBL] [Abstract][Full Text] [Related]
11. Single-chain human follicle-stimulating hormone with a di-N-glycosylated linker.
Nguyen TMD; Nguyen TT; Combarnous Y
Theriogenology; 2024 Aug; 224():50-57. PubMed ID: 38733814
[TBL] [Abstract][Full Text] [Related]
12. A 30-day preclinical safety evaluation study of recombinant human follicle-stimulating hormone in female rhesus monkeys.
Cai Y; Chen Z; Zhang Z; Zhang L; Li M; Liu C
Int J Toxicol; 2011 Mar; 30(2):153-61. PubMed ID: 21402952
[TBL] [Abstract][Full Text] [Related]
13. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.
Devroey P; Fauser BC; Platteau P; Beckers NG; Dhont M; Mannaerts BM
J Clin Endocrinol Metab; 2004 May; 89(5):2062-70. PubMed ID: 15126522
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility.
Balen AH; Mulders AG; Fauser BC; Schoot BC; Renier MA; Devroey P; Struijs MJ; Mannaerts BM
J Clin Endocrinol Metab; 2004 Dec; 89(12):6297-304. PubMed ID: 15579793
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of recombinant human follicle-stimulating hormone. III. Pharmacokinetic-pharmacodynamic modeling after repeated subcutaneous administration.
Porchet HC; le Cotonnec JY; Loumaye E
Fertil Steril; 1994 Apr; 61(4):687-95. PubMed ID: 8150111
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.
Fauser BC; Alper MM; Ledger W; Schoolcraft WB; Zandvliet A; Mannaerts BM;
Reprod Biomed Online; 2010 Nov; 21(5):593-601. PubMed ID: 20843746
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The French Multicentre Trialists.
Frydman R; Howles CM; Truong F
Hum Reprod; 2000 Mar; 15(3):520-5. PubMed ID: 10686190
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of a novel long-acting recombinant follicle stimulating hormone agonist by fusing Fc to an FSH-β subunit.
Zhang YL; Guo KP; Ji SY; Liu XM; Wang P; Wu J; Gao L; Jiang TQ; Xu T; Fan HY
Hum Reprod; 2016 Jan; 31(1):169-82. PubMed ID: 26621853
[TBL] [Abstract][Full Text] [Related]
19. Replacement with recombinant human inhibin immediately after orchidectomy in the hypophysiotropically clamped male rhesus monkey (Macaca mulatta) maintains follicle-stimulating hormone (FSH) secretion and FSH beta messenger ribonucleic acid levels at precastration values.
Majumdar SS; Mikuma N; Ishwad PC; Winters SJ; Attardi BJ; Perera AD; Plant TM
Endocrinology; 1995 May; 136(5):1969-77. PubMed ID: 7720645
[TBL] [Abstract][Full Text] [Related]
20. Single-chain bifunctional vascular endothelial growth factor (VEGF)-follicle-stimulating hormone (FSH)-C-terminal peptide (CTP) is superior to the combination therapy of recombinant VEGF plus FSH-CTP in stimulating angiogenesis during ovarian folliculogenesis.
Trousdale RK; Pollak SV; Klein J; Lobel L; Funahashi Y; Feirt N; Lustbader JW
Endocrinology; 2007 Mar; 148(3):1296-305. PubMed ID: 17122074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
